Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study (Q44174117)

30 November 2017

title

Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study (English)

1 reference

30 November 2017

1 reference

Violetta Klimek

1

1 reference

30 November 2017

Jane E Schenck

2

1 reference

30 November 2017

Hui Han

3

1 reference

30 November 2017

Craig A Stockmeier

4

1 reference

30 November 2017

Gregory A Ordway

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

30 November 2017

published in

Biological Psychiatry

1 reference

30 November 2017

volume

52

1 reference

30 November 2017

issue

7

1 reference

30 November 2017

page(s)

740-748

1 reference

Metabolic rate in the right amygdala predicts negative affect in depressed patients

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

The contribution of the amygdala to normal and abnormal emotional states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

The family history method using diagnostic criteria. Reliability and validity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Quantitative histochemistry of acetylcholinesterase in rat and human brain postmortem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Immunocytochemical localization of the dopamine transporter in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

The dopamine transporter: immunochemical characterization and localization in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Sleep deprivation increases dopamine D1 receptor antagonist [3H]SCH 23390 binding and dopamine-stimulated adenylate cyclase in the rat limbic system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Dopamine D2 receptors in depression measured with single photon emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Neuroimaging studies of mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

A functional anatomical study of unipolar depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Dopamine and depression--striatal dopamine D2 receptor SPECT before and after antidepressant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Neural degeneration and the transport of neurotransmitters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

A diagnostic interview: the schedule for affective disorders and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Antidepressant drugs affect dopamine uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Repeated administration of antidepressants enhances agonist affinity for mesolimbic D2-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Reduced levels of norepinephrine transporters in the locus coeruleus in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Recent biochemical studies of the dopamine transporter--a CNS drug target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Cocaine use increases [3H]WIN 35428 binding sites in human striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Cell-type-specific expression of catecholamine transporters in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Limbic-cortical dysregulation: a proposed model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Repeated reserpine administration up-regulates the transduction mechanisms of D1 receptors without changing the density of [3H]SCH 23390 binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Dopamine transporter immunohistochemistry in median eminence, amygdala, and other areas of the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Clinical and psychometric correlates of dopamine D2 binding in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

The effect of chronic treatment with a novel aryl-piperazine antipsychotic on monoamine receptors in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Amygdala core nuclei volumes are decreased in recurrent major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

The human amygdaloid complex: A cytologic and histochemical atlas using Nissl, myelin, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate diaphorase staining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

D1 dopamine receptor binding in mood disorders measured by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Reserpine-induced up-regulation of dopamine D2 receptors in the rat striatum is enhanced by denervation but not by chronic receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Effect of reserpine on the monoamine oxidase (MAO) activity in rat liver and brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Dopamine and depression: A review of recent evidence. II. Theoretical approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Dopamine Transporter Changes in Neuropsychiatric Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

Expression and regulation of the human dopamine transporter in a neuronal cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901383-5

10.1016/S0006-3223(02)01383-5

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference